Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / *W EXP 02/10/202
-
Total 13F shares
-
1,785,778
-
Share change
-
-16,760
-
Total reported value
-
$266,747
-
Price per share
-
$0.20
-
Number of holders
-
10
-
Value change
-
-$3,906
-
Number of buys
-
1
-
Number of sells
-
3
Institutional Holders of NUVATION BIO INC - *W EXP 02/10/202 (NUVBWS) as of Q1 2025
As of 31 Mar 2025,
NUVATION BIO INC - *W EXP 02/10/202 (NUVBWS) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,785,778 shares.
The largest 10 holders included
Decheng Capital LLC, Greenland Capital Management LP, FRANKLIN RESOURCES INC, BlackRock, Inc., Rock Springs Capital Management LP, ACUTA CAPITAL PARTNERS, LLC, Logos Global Management LP, VICTORY CAPITAL MANAGEMENT INC, Intellectus Partners, LLC, and UBS Group AG.
This page lists
10
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.